1. Effect of tegoprazan, a novel potassium-competitive acid blocker, on non-steroidal anti-inflammatory drug (NSAID)-induced enteropathy.
- Author
-
Lee HJ, Moon JW, Koh SJ, Im JP, Kim BG, and Kim JS
- Subjects
- Humans, Caco-2 Cells, Cell Proliferation drug effects, HT29 Cells, Cell Survival drug effects, Epithelial Cells drug effects, Epithelial Cells metabolism, Intestinal Mucosa drug effects, Intestinal Mucosa metabolism, Intestinal Mucosa pathology, Cytokines metabolism, Intestinal Diseases chemically induced, Intestinal Diseases metabolism, Intestinal Diseases pathology, Intestinal Diseases drug therapy, Cell Line, Tight Junction Proteins metabolism, Anti-Inflammatory Agents, Non-Steroidal pharmacology, Apoptosis drug effects, Indomethacin adverse effects
- Abstract
As the non-steroidal anti-inflammatory drugs (NSAIDs) are typically used in the treatment of chronic conditions, the incidence of NSAID-induced enteropathy is increasing. Given the challenges associated with discontinuing NSAIDs, effective preventive and treatment strategies are crucial. We assessed the effect of tegoprazan on NSAID-induced enteropathy. Human epithelial cells (HIEC-6, HT-29, and Caco-2) were treated with indomethacin and tegoprazan. Cell viability, expression levels of tight-junction proteins, levels of proinflammatory cytokines, and apoptosis were assessed by conducting MTT assays, RT-PCR, western blotting, and immunofluorescence staining, respectively. Tegoprazan significantly ameliorated the inhibition of cell proliferation induced by indomethacin. Tegoprazan also mitigated the suppression of occludin and ZO-1 expression by indomethacin, thereby restoring intestinal permeability. Additionally, tegoprazan reversed the indomethacin-induced elevation of the levels of proinflammatory cytokines and the rate of apoptosis of small intestinal epithelial cells. Our findings indicate that tegoprazan exerts a protective effect against NSAID-induced injury to small intestinal epithelial cells. The effect involves enhancement of the expression levels of tight junction proteins and the suppression of inflammation and apoptosis., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF